These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20720607)

  • 21. Use of sulfasalazine in rheumatic diseases.
    Fuchs HA
    Bull Rheum Dis; 1997 Nov; 46(7):3-4. PubMed ID: 9366125
    [No Abstract]   [Full Text] [Related]  

  • 22. Sulfasalazine-induced hypersensitivity: a case report of DRESS syndrome.
    Yeşilova Z; Kantarcioğlu M; Erçin CN; Safalioğlu M; Kilciler G; Koç E; Atli M; Uygun A
    Turk J Gastroenterol; 2009 Dec; 20(4):298-9. PubMed ID: 20084578
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adverse effects of DMARDs in treatment of rheumatoid arthritis].
    Sugii S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():566-72. PubMed ID: 15799419
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
    van Riel PL; van Gestel AM; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of severe pulmonary infiltration with eosinophilia (PIE) syndrome induced by sulphasalazine.
    Haroon M; Harney S
    Int J Rheum Dis; 2012 Dec; 15(6):e150-2. PubMed ID: 23253243
    [No Abstract]   [Full Text] [Related]  

  • 26. [Methotrexate-induced lung pathology in patients with rheumatoid arthritis].
    Murav'ev IuV; Udel'nova IA
    Klin Med (Mosk); 2001; 79(7):11-6. PubMed ID: 11523340
    [No Abstract]   [Full Text] [Related]  

  • 27. Salazosulfapyridine-induced hypersensitivity syndrome triggered by methotrexate.
    Teraki Y; Izaki S
    Clin Exp Dermatol; 2009 Oct; 34(7):e287-8. PubMed ID: 19438549
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-related pulmonary problems in patients with rheumatoid arthritis.
    Saravanan V; Kelly C
    Rheumatology (Oxford); 2006 Jul; 45(7):787-9. PubMed ID: 16527879
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pulmonary adverse effects caused by salazosulfapyridine].
    Kromann-Andersen H
    Ugeskr Laeger; 1998 Mar; 160(14):2131-2. PubMed ID: 9604688
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.
    Capell HA; Pullar T; Hunter JA
    Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Life-threatening liver failure and severe dyscrasias in blood and lymph nodes caused by sulphasalazine].
    Kampmann P; Højlyng N; Pedersen M
    Ugeskr Laeger; 2006 Sep; 168(39):3331-3. PubMed ID: 17032600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacotherapy of patients with (early) rheumatoid arthritis].
    van Rijthoven AW
    Ned Tijdschr Geneeskd; 2000 Mar; 144(11):539. PubMed ID: 10735141
    [No Abstract]   [Full Text] [Related]  

  • 33. Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.
    Quallich LG; Greenson J; Haftel HM; Fontana RJ
    BMC Gastroenterol; 2001; 1():8. PubMed ID: 11570976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.
    Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I
    Ann Rheum Dis; 2007 Feb; 66(2):235-41. PubMed ID: 16926184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of breathlessness.
    Shafei R; Goalby R; Hutchinson J
    BMJ; 2015 Jul; 351():h3515. PubMed ID: 26185147
    [No Abstract]   [Full Text] [Related]  

  • 36. Favourable issue of a fulminant hepatitis associated with sulfasalazine DRESS syndrome without liver transplantation.
    Descloux E; Argaud L; Dumortier J; Scoazec JY; Boillot O; Robert D
    Intensive Care Med; 2005 Dec; 31(12):1727-8. PubMed ID: 16283166
    [No Abstract]   [Full Text] [Related]  

  • 37. The 3-week sulphasalazine syndrome strikes again.
    Lau G; Kwan C; Chong SM
    Forensic Sci Int; 2001 Nov; 122(2-3):79-84. PubMed ID: 11672959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of salazosulfapyridine induced hypersensitivity syndrome].
    Orita M; Katakura Y; Kobayashi M; Ishii T; Watanabe Y; Yotsuyanagi H; Suzuki M; Itoh F
    Nihon Shokakibyo Gakkai Zasshi; 2005 May; 102(5):600-4. PubMed ID: 15920959
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gold salt-induced lung disease].
    Hernández Pérez JM; Acosta Fernández O; Castro López-Tarruella V
    Arch Bronconeumol; 2004 Nov; 40(11):540. PubMed ID: 15530348
    [No Abstract]   [Full Text] [Related]  

  • 40. Sulfasalazine-induced myopathy in a patient with an acute spondyloarthritis.
    Caterson HC; Youssef P
    Intern Med J; 2022 Jan; 52(1):155. PubMed ID: 35060279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.